Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial - Sillesen, Henrik; Amarenco, Pierre; Hennerici, Michael G.; Callahan, Alfred; Goldstein, Larry B.; Zivin, Justin; Messig, Michael; Welch, K. Michael (Stroke, 2008)
Gesehen am 24.03.2021